Meta-analysis by Flatow et al. (2013), mentioned above, has confirmed decrease in SOD activity in patients with schizophrenia according to cross-sectional investigations in the first psychotic episode, in remission and in the state of exacerbation. The gene discussed is SOD1; the disease is schizophrenia.